Information Provided By: 
Fly News Breaks for July 19, 2016
MZOR, ZBH
Jul 19, 2016 | 08:49 EDT
Needham analyst Mike Matson raised his price target for Zimmer Biomet (ZBH) to $143 from $134 after the company announced it is acquiring robotics company Medtech, which he sees as positive. Although Medtech's business has been more brain-oriented, the analyst expects this to change given Zimmer Biomet's large spine implant business. As a result Matson views Medtech's ROSA robot as more of a threat to Mazor Robotics (MZOR). Needham has a Buy rating on Zimmer Biomet's shares.
News For ZBH;MZOR From the Last 2 Days
There are no results for your query ZBH;MZOR
